Cargando…
Malignant hyperthermia
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane and the depolarizing muscle relaxant succinylcholine, and rarely, in humans, to stresses such as vigo...
Autores principales: | Rosenberg, Henry, Davis, Mark, James, Danielle, Pollock, Neil, Stowell, Kathryn |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1867813/ https://www.ncbi.nlm.nih.gov/pubmed/17456235 http://dx.doi.org/10.1186/1750-1172-2-21 |
Ejemplares similares
-
Malignant hyperthermia: a review
por: Rosenberg, Henry, et al.
Publicado: (2015) -
Functional analysis of RYR1 variants linked to malignant hyperthermia
por: Stephens, Jeremy, et al.
Publicado: (2016) -
Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia
por: Parker, Remai, et al.
Publicado: (2017) -
Variant Curation Expert Panel Recommendations for RYR1 Pathogenicity Classifications in Malignant Hyperthermia Susceptibility
por: Johnston, Jennifer J., et al.
Publicado: (2021) -
Development and evolution of the MHAUS cognitive aid for malignant hyperthermia
por: Pinyavat, Teeda, et al.
Publicado: (2014)